Researchers created an experimental treatment for von Willebrand disease (VWD) type 1 that aims to stabilize the protein whose defect causes the disease, increasing…
Von Willebrand disease
Von Willebrand disease is a genetic bleeding disorder that impairs the body’s ability to form proper blood clots. It can cause frequent or prolonged bleeding episodes, but many people experience only mild or manageable symptoms.
Treatment for von Willebrand disease focuses on preventing and controlling bleeding to improve daily life and reduce serious risks. Management plans vary by disease type and may involve ongoing monitoring and personalized care strategies.
Latest news
Star Therapeutics has raised $125 million to support the development of VGA039, a treatment for von Willebrand disease (VWD) and other bleeding disorders…